Title: Filipski KJ, et al. Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1). ACS Med Chem Lett. 2018 Apr 12;9(5):440-445.
1119517-19-9 | GLP-1(7-36) Acetate | AA01EOKC | MFCD18074453
308362-25-6 | Ridinilazole | AA01EOPE | MFCD28963972
1869980-05-1 | (1-butyl-6-methoxy-1H-indol-3-yl)-1-naphthalenyl-methanone | AA01EOXU
869577-51-5 | N-[4-[4-[(2-oxiranylmethyl)sulfonyl]phenoxy]phenyl]-methanesulfonamide | AA01EP7Y | MFCD24369005
122882-90-0 | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-pentanamide | AA01EPGB
526191-19-5 | 5-oxo-5-[phenyl[1-(2-phenylethyl)-4-piperidinyl]amino]-pentanoicacid | AA01EPLI
1420071-13-1 | 1-[2-[[(cyclopropylcarbonyl)ethylamino]methyl]-4-(trifluoromethyl)phenyl]-6-methyl-1H-pyrrolo[2,3-b]pyridine-3-aceticacid | AA01EPS8
2121543-66-4 | 25-[[1-(3α)-cholest-5-en-3-yl-1H-1,2,3-triazol-4-yl]methoxy]-26,27,28-trihydroxy-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17-triaceticacid,trisodiumsalt | AA01EQ1B
2055172-61-5 | (4-[1,1'-biphenyl]-4-yl-1H-1,2,3-triazol-1-yl)[(2S)-2-(phenylmethyl)-1-piperidinyl]-methanone | AA01EQ8F
931314-31-7 | SPA70-LC-1|SpecificPXRantagonist70 | AA01EQD9 | MFCD14774311